Fused pyrazole as p38 MAP kinase inhibitors

Details for Australian Patent Application No. 2006283935 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Gabriel, Tobias; Dewdney, Nolan James; Arora, Nidhi; Billedeau, Roland Joseph; Trejo-Martin, Teresa Alejandra; Soth, Michael; Goldstein, David Michael; O'Yang, Counde

Agent Davies Collison Cave

Pub. Number AU-A-2006283935

PCT Pub. Number WO2007/023105

Priority 60/712,012 25.08.05 US

Filing date 15 August 2006

Wipo publication date 1 March 2007

International Classifications

A61K 31/4162 (2006.01) - condensed with heterocyclic ring systems

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/023105 Priority application(s): WO2007/023105

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283940-P38 MAP kinase inhibitors and methods for using the same

2006283929-Herbicidal mixtures of cinmethylin